New Study Results Indicate Superior Absorption of RLF-OD032 in Fasted State Compared to KUVAN ®, Potentially Enabling Flexible Dosing Options The patent filings follow the recently announced ...
GENEVA (OCT. 25, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback